Artemis Investment Management LLP
Position in BMY — Bristol Myers Squibb Co
CIK 1535385
EDINBURGH, X0
Position in BMY
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$175,941,517
+$948,194 QoQ
Shares Held
3,053,480
+5.8% QoQ
Ownership
0.149%
of shares outstanding
% of Portfolio
1.57%
of 13F equity value
Holder Rank
#76
of 2,506 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Artemis Investment Management LLP holds $978,265,315 across 7 Drug Manufacturers - General names. BMY ranks #3 (18.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
1,279,269 | $242,574,987 | |
| 2 | PFE |
Pfizer Inc
|
7,612,597 | $183,311,335 | |
| 3 | BMY |
Bristol Myers Squibb Co
This page
|
3,053,480 | $175,941,517 | |
| 4 | BIIB |
Biogen Inc.
|
570,974 | $123,364,642 | |
| 5 | ABBV |
AbbVie Inc.
|
482,591 | $121,439,199 | |
| 6 | LLY |
ELI LILLY & Co
|
95,948 | $115,082,919 | |
| 7 | JNJ |
Johnson & Johnson
|
65,168 | $16,550,716 |
All Filings in BMY
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $175,941,517 | 3,053,480 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $174,993,323 | 2,885,298 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $93,896,216 | 1,740,753 | Shares | Sole | 2026-02-02 | |
| 2025-03-31 | $14,767,569 | 242,131 | Shares | Sole | 2025-04-24 | |
| 2023-06-30 | $2,589,079 | 40,486 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $106,204,267 | 1,532,308 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $135,520,703 | 1,883,540 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $142,106,137 | 1,998,961 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $150,721,340 | 1,957,420 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $145,066,718 | 1,986,399 | Shares | Sole | 2022-04-21 | |
| 2021-09-30 | $11,551,404 | 195,224 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $8,754,088 | 131,010 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $56,148,579 | 889,412 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $62,059,898 | 1,000,482 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $62,733,975 | 1,040,537 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $71,564,421 | 1,217,082 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $101,105,002 | 1,813,868 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||